Clinical trials
Phase 3 Coronary Artery Disease trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
100 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 1 |
| 2002 | 5 |
| 2003 | 9 |
| 2004 | 5 |
| 2005 | 6 |
| 2006 | 8 |
| 2007 | 7 |
| 2008 | 3 |
| 2009 | 13 |
| 2010 | 1 |
| 2011 | 4 |
| 2012 | 4 |
| 2013 | 7 |
| 2014 | 2 |
| 2015 | 3 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 6 |
| 2020 | 2 |
| 2022 | 2 |
| 2023 | 1 |
| 2024 | 4 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 72 |
| Terminated | 12 |
| Active, not recruiting | 5 |
| Unknown status | 4 |
| Withdrawn | 2 |
| Recruiting | 2 |
| Suspended | 2 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Boston Scientific Corporation | 13 |
| Cordis US Corp. | 6 |
| AstraZeneca | 4 |
| Abbott Medical Devices | 3 |
| Acusphere | 3 |
| Bayer | 3 |
| Brigham and Women's Hospital | 3 |
| Forest Laboratories | 3 |
| GE Healthcare | 3 |
| Gilead Sciences | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Coronary Artery Disease | 100 |
| Heart Diseases | 12 |
| Myocardial Infarction | 9 |
| Acute Coronary Syndrome | 8 |
| Coronary Disease | 6 |
| Coronary Stenosis | 6 |
| Ischemia | 5 |
| Myocardial Ischemia | 5 |
| Stroke | 5 |
| Angina Pectoris | 4 |
Trials
Showing 1 to 25 of 100. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.